{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:29:54Z","timestamp":1769304594205,"version":"3.49.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.heliyon.2022.e12172","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T20:03:13Z","timestamp":1670529793000},"page":"e12172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3577-5303","authenticated-orcid":false,"given":"Bruna Stefane Alves de","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora Sandrini","family":"Milanezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila do Val","family":"Gonzaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Rabello","family":"Detoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-8120","authenticated-orcid":false,"given":"Renato Nery","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2022.e12172_bib1","article-title":"Does the gut microbiota influence immunity and inflammation in multiple sclerosis pathophysiology?","volume":"2017","author":"Adamczyk-Sowa","year":"2017","journal-title":"J\u00a0Immunol Res"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer's disease anti-inflammatory prevention trial and its follow-up study","volume":"11","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.heliyon.2022.e12172_bib3","doi-asserted-by":"crossref","first-page":"25-35","DOI":"10.1016\/j.bbi.2019.07.028","article-title":"Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome","volume":"82","author":"Al-Ghezi","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/jpet.110.168237","article-title":"Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability","volume":"335","author":"Alhamoruni","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12172_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jalz.2012.11.012","article-title":"Results of a follow-up study to the randomized Alzheimer's disease anti-inflammatory prevention trial (ADAPT)","volume":"9","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12172_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J.\u00a0Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-150913","article-title":"Cannabinoid receptor 2 participates in amyloid-\u03b2 processing in a mouse model of Alzheimer's disease but plays a minor role in the therapeutic properties of a cannabis-based medicine","volume":"51","author":"Aso","year":"2016","journal-title":"J.\u00a0Alzheimers Dis"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12172_bib9","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1007\/s12035-018-1456-3","article-title":"Adenosine A2A-cannabinoid CB1 receptor heteromers in the Hippocampus: cannabidiol blunts \u03949-tetrahydrocannabinol-induced cognitive impairment","volume":"56","author":"Aso","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12172_bib10","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3390\/ijms21082850","article-title":"Endocannabinoid-mediated neuromodulation in the olfactory bulb: functional and therapeutic significance","volume":"21","author":"Bhatia-Dey","year":"2020","journal-title":"Int. J. Mol. Sci"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e12172_bib13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e12172_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00109-009-0512-x","article-title":"Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis","volume":"87","author":"Borrelli","year":"2009","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"issue":"263","key":"10.1016\/j.heliyon.2022.e12172_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2022.e12172_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"20","key":"10.1016\/j.heliyon.2022.e12172_bib19","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12172_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-130050","article-title":"Natural cannabinoids improve dopamine neurotransmission and tau and\u00a0amyloid pathology in a mouse model of tauopathy","volume":"35","author":"Casarejos","year":"2013","journal-title":"J.\u00a0Alzheim. Dis."},{"key":"10.1016\/j.heliyon.2022.e12172_bib21","doi-asserted-by":"crossref","unstructured":"Cattaneo A., Cattane N.,Galluzi S., Provasi S., Lopizzo N.,Festari C., et\u00a0al. 2017; 49:60-68. doi: .","DOI":"10.1016\/j.neurobiolaging.2016.08.019"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12172_bib22","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3390\/nu13062099","article-title":"Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders","volume":"13","author":"Chen","year":"2021","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.heliyon.2022.e12172_bib23","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u0394E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12172_bib24","doi-asserted-by":"crossref","first-page":"608-620","DOI":"10.1016\/j.it.2016.06.006","article-title":"Astrocytes: key regulators of neuroinflammation","volume":"37","author":"Colombo","year":"2016","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ibd\/izy014","article-title":"The use of cannabinoids in colitis: a systematic review and meta-analysis","volume":"24","author":"Couch","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12172_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ibd\/izz017","article-title":"Palmitoylethanolamide and cannabidiol prevent inflammation-induced hyperpermeability of the human gut in vitro and in vivo-A randomized, placebo-controlled, double-blind controlled trial","volume":"25","author":"Couch","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib28","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain Axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"issue":"19","key":"10.1016\/j.heliyon.2022.e12172_bib30","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.3390\/ijms20194704","article-title":"Microbiome influence in the pathogenesis of prion and Alzheimer's diseases","volume":"20","author":"D'Argenio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12035-016-0356-7","article-title":"Brain barrier breakdown as a cause and consequence of neuroinflammation in sepsis","volume":"55","author":"Danielski","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12172_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028159","article-title":"Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis","volume":"6","author":"De Filippis","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2022.e12172_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.phrs.2018.07.007","article-title":"Relevance of gutmicrobiota in cognition, behaviour and Alzheimer's disease","volume":"136","author":"De-Paula","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1113\/JP273106","article-title":"Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration","volume":"595","author":"Dinan","year":"2017","journal-title":"J.\u00a0Physiol."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12172_bib36","doi-asserted-by":"crossref","first-page":"870-882","DOI":"10.2174\/1567205014666170317113606","article-title":"Impact of cytokines and chemokines on Alzheimer's disease neuropathological hallmarks","volume":"14","author":"Domingues","year":"2017","journal-title":"Curr. Alzheimer Res."},{"issue":"26","key":"10.1016\/j.heliyon.2022.e12172_bib37","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.2174\/1381612826666200210111925","article-title":"Development of a novel oral delivery vehicle for probiotics","volume":"26","author":"Enck","year":"2020","journal-title":"Curr. Pharmaceut. Des."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12172_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"issue":"1-2","key":"10.1016\/j.heliyon.2022.e12172_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12172_bib40","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12172_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib42","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-170045","article-title":"Mouse models of Alzheimer\u2019s disease","volume":"57","author":"Esquerda-Canals","year":"2017","journal-title":"J.\u00a0Alzheim. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14129","article-title":"Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective","volume":"1449","author":"Fox","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12172_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006654","article-title":"The role of microbial amyloid in neurodegeneration","volume":"13","author":"Friedland","year":"2017","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.4476","article-title":"Interactions between the microbiota, immune and nervous systems in health and disease","volume":"20","author":"Fung","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"10062","key":"10.1016\/j.heliyon.2022.e12172_bib47","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2022.e12172_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.810483","article-title":"Enteric nervous system: the bridge between the gut microbiota and neurological disorders","volume":"14","author":"Geng","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e12172_bib49","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/nu10111765","article-title":"Gut microbiota and their neuroinflammatory implications in Alzheimer's disease","volume":"10","author":"Giau","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2022.e12172_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-3-5","article-title":"Interleukin-1 mediates Alzheimer and Lewy body pathologies","volume":"3","author":"Griffin","year":"2006","journal-title":"J.\u00a0Neuroinflammation"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.heliyon.2022.e12172_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118624","article-title":"Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP\/PS1 Alzheimer's mice uncovered by RNA-seq","volume":"264","author":"Hao","year":"2021","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib53","doi-asserted-by":"crossref","first-page":"388-405","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12172_bib54","doi-asserted-by":"crossref","first-page":"794-799","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamaneurol.2019.3762","article-title":"Minocycline at 2 different dosages vs placebo for patients with mild alzheimer disease: a randomized clinical trial","volume":"77","author":"Howard","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and Alzheimer's disease","volume":"58","author":"Jiang","year":"2017","journal-title":"J.\u00a0Alzheim. Dis.: JAD."},{"key":"10.1016\/j.heliyon.2022.e12172_bib57","first-page":"l6217","article-title":"Cognitive symptoms of Alzheimer's disease: clinical management and prevention","volume":"367","author":"Joe","year":"2019","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.heliyon.2022.e12172_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.711639","article-title":"Cannabidiol exposure during the mouse adolescent period is without harmful behavioral effects on locomotor activity, anxiety, and spatial memory","volume":"15","author":"Kaplan","year":"2021","journal-title":"Front. Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12172_bib59","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3233\/JAD-210026","article-title":"Cannabidiol ameliorates cognitive function via regulation of IL-33 and TREM2 upregulation in a murine model of Alzheimer's disease","volume":"80","author":"Khodadadi","year":"2021","journal-title":"J.\u00a0Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","article-title":"Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model","volume":"69","author":"Kim","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2022.e12172_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/748212","article-title":"Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer's disease","volume":"2015","author":"Kirova","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12172_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002660","article-title":"Nilvadipine in mild to moderate Alzheimer disease: a randomised controlled trial","volume":"15","author":"Lawlor","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.heliyon.2022.e12172_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112163","article-title":"Overview of cannabidiol (CBD) and its analogues: structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease","volume":"192","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib66","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neurobiolaging.2012.05.017","article-title":"Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases","volume":"34","author":"Liu","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12172_bib67","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cns.13190","article-title":"Research progress on adenosine in central nervous system diseases","volume":"25","author":"Liu","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.heliyon.2022.e12172_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2530414","article-title":"Contribution of neurons and glial cells to complement-mediated synapse removal during development, aging and in Alzheimer's disease","volume":"2018","author":"Luchena","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"24","key":"10.1016\/j.heliyon.2022.e12172_bib70","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2022.e12172_bib72","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2017.12.009","article-title":"Alzheimer's disease and gut microbiota. Modifications: the long way between preclinical studies and clinical evidence","volume":"129","author":"Mancuso","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib73","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-200306","article-title":"Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer's disease","volume":"78","author":"Marizzoni","year":"2020","journal-title":"J.\u00a0Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12172_bib74","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tim.2012.12.001","article-title":"Development of intestinal microbiota in infants and its impact on health","volume":"21","author":"Matamoros","year":"2013","journal-title":"Trends Microbiol"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e12172_bib76","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/psyg.12581","article-title":"Effect of Feru-guard 100M on amyloid-beta deposition in individuals with mild cognitive impairment","volume":"20","author":"Matsuyama","year":"2020","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.heliyon.2022.e12172_bib77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"24","key":"10.1016\/j.heliyon.2022.e12172_bib78","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.2174\/0929867328666211129122550","article-title":"A2A adenosine receptor antagonists in neurodegenerative diseases","volume":"29","author":"Merighi","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12172_bib79","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.3390\/molecules27092680","article-title":"Pathophysiological role and medicinal chemistry of A2A adenosine receptor antagonists in Alzheimer's disease","volume":"27","author":"Merighi","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12172_bib80","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.3390\/ijms23095056","article-title":"A2A adenosine receptor: a possible therapeutic target for Alzheimer's disease by regulating NLRP3 inflammasome activity?","volume":"23","author":"Merighi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e12172_bib81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2018.08.037","article-title":"Gut microbiota, cannabinoid system and neuroimmune interactions: new perspectives in multiple sclerosis","volume":"157","author":"Mestre","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12172_bib82","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/acn3.788","article-title":"No apparent effect of naproxen on CSF markers of innate immune activation","volume":"6","author":"Meyer","year":"2019","journal-title":"Ann .Clin. Transl. Neurol"},{"key":"10.1016\/j.heliyon.2022.e12172_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109951","article-title":"The HPA axis dysregulation in severe mental illness: can we shift the blame to gut microbiota?","volume":"102","author":"Misiak","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.heliyon.2022.e12172_bib84","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopha.2018.12.118","article-title":"A\u00a0pilot study on the effect of lactoferrin on Alzheimer's disease pathological sequelae: impact of the p-Akt\/PTEN pathway","volume":"111","author":"Mohamed","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib85","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12172_bib87","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cid\/cis1023","article-title":"Infection, illness, and fenugreek seeds: was illness a good enough proxy for infection in the 2011 outbreak of shiga toxin-producing Escherichia coli O104:H4 in France?","volume":"56","author":"Morgan","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12172_bib88","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/molecules27072366","article-title":"The pharmacological potential of adenosine A2A receptor antagonists for treating Parkinson's disease","volume":"27","author":"Mori","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","article-title":"Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease","volume":"14","author":"Moussa","year":"2017","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.heliyon.2022.e12172_bib90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/msb.2010.46","article-title":"The endocannabinoid system links gut microbiota to adipogenesis","volume":"6","author":"Muccioli","year":"2010","journal-title":"Mol. Syst. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib91","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1002\/cpns.81","article-title":"Overview of transgenic mouse models for Alzheimer's disease","volume":"89","author":"Myers","year":"2019","journal-title":"Curr. Protoc. Neurosci"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12172_bib92","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/nmo.12378","article-title":"Correlation between the human fecal microbiota and depression","volume":"26","author":"Naseribafrouei","year":"2014","journal-title":"Neuro Gastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73729-2","article-title":"Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression","volume":"10","author":"Noguchi-Shinohara","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2022.e12172_bib94","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fphar.2016.00341","article-title":"An orally active Cannabis extract with high content in cannabidiol attenuates chemically-induced intestinal inflammation and hypermotility in the mouse","volume":"7","author":"Pagano","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e12172_bib95","doi-asserted-by":"crossref","first-page":"30-38","DOI":"10.1016\/j.neulet.2013.12.071","article-title":"The dual role of astrocyte activation and reactive gliosis","volume":"565","author":"Pekny","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e12172_bib96","doi-asserted-by":"crossref","first-page":"624-634","DOI":"10.1093\/nutrit\/nuw023","article-title":"Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease","volume":"74","author":"Pistollato","year":"2016","journal-title":"Nutr. Rev."},{"issue":"7418","key":"10.1016\/j.heliyon.2022.e12172_bib97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A\u00a0metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12172_bib99","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1017\/S0007114516001203","article-title":"Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults","volume":"115","author":"Rainey-Smith","year":"2016","journal-title":"Br. J. Nutr."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e12172_bib100","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2174\/1567205014666170203141717","article-title":"Neuroinflammation and Alzheimer's disease: implications for microglial activation","volume":"14","author":"Regen","year":"2017","journal-title":"Curr. Alzheimer Res."},{"issue":"18","key":"10.1016\/j.heliyon.2022.e12172_bib101","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1523\/JNEUROSCI.3387-15.2016","article-title":"Cannabidiol counteracts amphetamine-induced neuronal and behavioral sensitization of the mesolimbic dopamine pathway through a novel mTOR\/p70S6 kinase signaling pathway","volume":"36","author":"Renard","year":"2016","journal-title":"J.\u00a0Neurosci."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12172_bib102","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2174\/13892037113149990144","article-title":"CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study","volume":"10","author":"Ross","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib103","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41590-019-0344-y","article-title":"Infection drives meningeal engraftment by inflammatory monocytes that impairs CNS immunity","volume":"20","author":"Rua","year":"2019","journal-title":"Nat. Immunol."},{"issue":"32","key":"10.1016\/j.heliyon.2022.e12172_bib104","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.2174\/0929867324666170216113756","article-title":"Gut-brain Axis: role of lipids in the regulation of inflammation, pain and CNS diseases","volume":"25","author":"Russo","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12172_bib105","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1212\/WNL.0000000000009277","article-title":"Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline","volume":"95","author":"Ryan","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e12172_bib106","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/JCP.0000000000001457","article-title":"Opposite roles for cannabidiol and \u03b4-9-tetrahydrocannabinol in psychotomimetic effects of Cannabis extracts: a naturalistic controlled study","volume":"41","author":"Sainz-Cort","year":"2021","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib107","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib108","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/tx700210j","article-title":"Oxidative stress and neurotoxicity","volume":"21","author":"Sayre","year":"2008","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pbb.2011.01.007","article-title":"Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists","volume":"98","author":"Scopinho","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib111","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1871527311312010011","article-title":"Neuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer's disease","volume":"12","author":"Scuderi","year":"2013","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12172_bib112","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother Res"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib113","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.heliyon.2022.e12172_bib114","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm. J."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12172_bib115","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41380-019-0396-2","article-title":"Sequential formation of different layers of dystrophic neurites in Alzheimer's brains","volume":"24","author":"Sharoar","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.heliyon.2022.e12172_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.585096","article-title":"Fish oil, cannabidiol and the gut microbiota: an investigation in a murine model of colitis","volume":"11","author":"Silvestri","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib117","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.116.232256","article-title":"The \u03b3-secretase modulator, BMS-932481, modulates A\u03b2 peptides in the plasma and cerebrospinal fluid of healthy volunteers","volume":"358","author":"Soares","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12172_bib118","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s12035-018-1188-4","article-title":"The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer's disease-a critical review","volume":"56","author":"Sochocka","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.heliyon.2022.e12172_bib119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuint.2018.08.005","article-title":"Unhealthy gut, unhealthy brain: the role of the intestinal microbiota in neurodegenerative diseases","volume":"120","author":"Spielman","year":"2018","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib120","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer's disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"issue":"Pt B","key":"10.1016\/j.heliyon.2022.e12172_bib121","first-page":"128","article-title":"Neurotransmitter modulation by the gut microbiota","volume":"1693","author":"Strandwitz","year":"2019","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib122","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3233\/JAD-170908","article-title":"Human gut microbiota in health and Alzheimer's disease","volume":"62","author":"Szablewski","year":"2018","journal-title":"J.\u00a0Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib124","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/nu12041032","article-title":"Dietary supplementation with curcumin reduce circulating levels of glycogen synthase kinase-3\u03b2 and islet amyloid polypeptide in adults with high risk of type 2 diabetes and Alzheimer's disease","volume":"12","author":"Thota","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib125","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"Tonnies","year":"2017","journal-title":"J.\u00a0Alzheimers Dis"},{"issue":"Pt 2","key":"10.1016\/j.heliyon.2022.e12172_bib126","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","article-title":"Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers","volume":"572","author":"Townsend","year":"2006","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.heliyon.2022.e12172_bib127","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.3389\/fimmu.2019.02655","article-title":"Interactions between gut microbiota and acute restraint stress in peripheral structures of the hypothalamic-pituitary-adrenal Axis and the intestine of male mice","volume":"10","author":"Vagnerov\u00e1","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e12172_bib128","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fnins.2016.00459","article-title":"Alzheimer disease: crosstalk between the canonical wnt\/beta-catenin pathway and PPARs alpha and gamma","volume":"10","author":"Vall\u00e9e","year":"2016","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s40168-021-01165-z","article-title":"Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia","volume":"9","author":"Vicentini","year":"2021","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12172_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13601-y","article-title":"Gut microbiome alterations in Alzheimer's disease","volume":"7","author":"Vogt","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12172_bib133","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-191242","article-title":"Chronic treatment with 50 mg\/kg cannabidiol improves cognition and moderately reduces A\u03b240 levels in 12-month-old male A\u03b2PPswe\/PS1\u0394E9 transgenic mice","volume":"74","author":"Watt","year":"2020","journal-title":"J.\u00a0Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2022.e12172_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172970","article-title":"Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58\/2 transgenic mice","volume":"196","author":"Watt","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2022.e12172_bib135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2147\/DDDT.S281575","article-title":"The volatile oil of zanthoxylum bungeanum pericarp improved the hypothalamic-pituitary-adrenal Axis and gut microbiota to attenuate chronic unpredictable stress-induced anxiety behavior in rats","volume":"15","author":"Wei","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12172_bib136","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/1568026615666150827095102","article-title":"Relationships between mitochondria and neuroinflammation: implications for Alzheimer's disease","volume":"16","author":"Wilkins","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"35","key":"10.1016\/j.heliyon.2022.e12172_bib137","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1523\/JNEUROSCI.1023-16.2016","article-title":"Environmental enrichment potently prevents microglia-mediated neuroinflammation by human amyloid \u03b2-protein oligomers","volume":"36","author":"Xu","year":"2016","journal-title":"J.\u00a0Neurosci."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12172_bib138","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib140","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/jgs.13310","article-title":"The microbiota and microbiome in aging: potential implications in health and age-related diseases","volume":"63","author":"Zapata","year":"2015","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12172_bib143","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3233\/JAD-170630","article-title":"Brazilian green propolis prevents cognitive decline into mild cognitive impairment in elderly people living at high altitude","volume":"63","author":"Zhu","year":"2018","journal-title":"J.\u00a0Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12172_bib145","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41422-022-00645-7","article-title":"Gut microbiota drives macrophage-dependent self-renewal of intestinal stem cells via niche enteric serotonergic neurons","volume":"32","author":"Zhu","year":"2022","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12172_bib146","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3233\/JAD-180176","article-title":"Gut microbiota is altered in patients with Alzheimer's disease","volume":"63","author":"Zhuang","year":"2018","journal-title":"J.\u00a0Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12172_bib147","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e12172_bib148","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022034600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022034600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:56:14Z","timestamp":1767102974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022034600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":127,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2405844022034600"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12172","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e12172"}}